Imunon, Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: IMNN · Form: 8-K · Filed: May 13, 2025 · CIK: 749647
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
TL;DR
Imunon (IMNN) filed an 8-K on May 12, 2025, reporting a material definitive agreement and unregistered equity sales.
AI Summary
On May 12, 2025, Imunon, Inc. filed an 8-K report detailing a material definitive agreement and unregistered sales of equity securities. The filing also includes financial statements and exhibits, with the report being filed as of May 13, 2025. Imunon, Inc. was formerly known as Celsion Corp.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered equity sales, which can introduce financial and operational risks for the company.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- Celsion Corp (company) — Former company name
- May 12, 2025 (date) — Date of earliest event reported
- May 13, 2025 (date) — Filed as of date
FAQ
What is the nature of the material definitive agreement entered into by Imunon, Inc. on May 12, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
What type of equity securities were sold in the unregistered sale reported by Imunon, Inc.?
The filing mentions unregistered sales of equity securities but does not specify the type or amount.
What are the key financial highlights or figures reported in the financial statements and exhibits filed with this 8-K?
The filing indicates that financial statements and exhibits are included, but the specific financial figures are not detailed in the provided text.
When did Imunon, Inc. change its name from Celsion Corp?
The filing indicates a name change from Celsion Corp to Imunon, Inc. occurred on November 21, 2007.
What is the primary business of Imunon, Inc. according to its SIC code?
Imunon, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Imunon, Inc. (IMNN).